Revvity

• Introducing over 1,500 new antibodies, kits, and reagents annually for life science research

• Supplying more than two million scientists across pharma, biotech, and academia with Revvity's software solutions

• Screening 40 million babies annually for life-threatening diseases across 110 countries

As a team of more than 11,000 employees across 190 countries, we offer both scale and agility. United, we can deliver custom, complete solutions from discovery to development, and diagnosis to cure.

Combined with our rapidly growing strength in automation, productivity, and workflow, we are uniquely positioned to accelerate health science innovation from bench to bedside. And this is just the beginning.

Our specialized areas of focus include translational multi-omics technologies, biomarker identification, imaging, prediction, screening and diagnosis, detection, informatics, and more.